Preparation method of 2-aminopyridine derivative
Patent Information
- Application Number
- CN202380016130.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-28
- Filing Date
- 2023-03-28
- Publication Date
- 2024-11-08
AI Technical Summary
The existing preparation method of 2-aminopyridine derivative compound VII has complicated column purification steps, high cost, and limited applicability, making it difficult to meet the needs of industrial production.
The preparation method of Compound VII was optimized. By simplifying the reaction conditions, the step of beating and crystallization was omitted, organic solvents were used to back-extract impurities, and the product was extracted after adjusting acid, avoiding silica gel column chromatography separation, and using salt transfer reagents to improve the yield. and purity, suitable for industrial production.
It achieves high yield and high purity preparation of compound VII, simplifies the operation process, reduces production costs, is suitable for industrial production, and improves preparation efficiency and product quality.
Smart Images

Figure CN118922424A_ABST
Abstract
Description
A preparation method of 2-aminopyridine derivatives Technical Field
[0001] The present invention relates to a method for preparing a 2-aminopyridine derivative. Background Art
[0002] Factor XIa (FXIa) is a key enzyme in the coagulation process. Selective inhibition of FXIa is expected to prevent pathological thrombosis while maintaining its physiological function of local hemostasis in response to tissue damage through the extrinsic pathway. This is likely due to FXIa's key role in the classic intrinsic coagulation pathway (activating FIX, which in turn activates FX) and its crucial role in mediating the burst of thrombin generation that occurs after tissue factor (TF) activates the extrinsic coagulation pathway. FXIa inhibition prevents both coagulation activation caused by contact with foreign surfaces (such as the extracorporeal circuit) and amplification of coagulation induced by exposure to tissue factor (surgical "injury"). Therefore, local coagulation reactions can still be triggered at the site of surgical incision or local trauma (through exposure to tissue factor). At the same time, because FXIa inhibitors block the thrombin amplification mechanism, the expansion of thrombi from smaller local vascular injuries to larger occlusive clots or emboli is significantly reduced or eliminated. This approach can ensure smooth extracorporeal circulation while reducing bleeding. Other potential benefits of FXIa inhibition over heparin may include preservation of coagulation cofactors during extracorporeal circulation, elimination of the risk of heparin-induced thrombocytopenia (HIT), easier use, and potentially lower risk of postoperative bleeding and subsequent complications.
[0003] Compound VII is a novel, potent, and selective small-molecule factor XIa inhibitor (FXIa) designed to prevent thrombosis and limit bleeding risk. Compound VII, previously codenamed EP-7041 HCl, was acquired by Hisense in 2019 from eXIthera, a US-based biotechnology company dedicated to the discovery and development of effective anticoagulants. Compound VII is intended for use in hemodialysis patients and systemic anticoagulation during surgery.
[0004] Patent WO2020092592A1 describes a method for preparing a compound of formula (VII), which requires column purification.
[0005] Summary of the Invention
[0006] The present invention relates to a method for preparing a 2-aminopyridine derivative, namely a method for preparing a compound represented by formula (VII). The method has mild reaction conditions, simple operation, high reaction yield, high product purity, convenient post-processing, and is suitable for industrial production.
[0007] The present invention optimizes the method for preparing formula (I) from formula (I) and formula (I-4), purifies the crude product by pulping, improves the purity of the intermediate of formula (I), and is suitable for industrial production.
[0008] The present invention optimizes the method for preparing formula (III) from formula (I) and formula (II), omitting the purification step of pulping and crystallization, removing impurities by back extraction with an organic solvent, adjusting the acid, and then extracting the product with an organic solvent. The operation is simpler, more suitable for industrial production, and greatly improves the yield of formula (III).
[0009] The present invention optimizes the method for preparing formula (V) from formula (III) and formula (IV), adopts a pulping method for purification, avoids column chromatography separation, is more suitable for industrial production, and greatly improves the yield of formula (V).
[0010] The present invention optimizes the method for preparing formula (VI) from formula (V), thereby greatly improving the purity of formula (VI).
[0011] The present invention optimizes the preparation method of the compound represented by formula (VII) and adopts a salt conversion reagent suitable for industrial production.
[0012] The present invention optimizes the synthesis yield of each intermediate, improves the overall yield, and thus reduces production costs.
[0013] The present invention optimizes the post-processing of each reaction step, avoids the use of silica gel column chromatography separation and purification, uses conventional simple operation steps, and is more suitable for industrial production.
[0014] The present invention provides a method for preparing compound (I), which is prepared by the following reaction:
[0015] In an aprotic solvent, a compound of formula (I-4) and a Pd / C catalyst are added, and a debenzylation reaction is carried out under a hydrogen atmosphere, and the compound of formula (I) is obtained after post-treatment;
[0016] The amount of the catalyst Pd / C is 9 to 15% of the mass of the compound of formula (I-4).
[0017] In some embodiments of the method for preparing compound (I) of the present invention, the amount of catalyst Pd / C used is 10-13% of the mass of the compound of formula (I-4).
[0018] In some embodiments of the method for preparing compound (I) according to the present invention, the amount of Pd in the catalyst Pd / C is 1 to 1.3% by mass of the compound of formula (I-4).
[0019] In some embodiments of the method for preparing compound (I) according to the present invention, the post-treatment comprises: filtering and concentrating the reaction solution to obtain a crude product, and slurrying the crude product.
[0020] In some embodiments of the method for preparing compound (I) according to the present invention, the post-treatment comprises beating the crude product.
[0021] In some embodiments of the preparation method of compound (I) according to the present invention, the solvent used for pulping is selected from one or a mixed solvent of two or more of aromatic hydrocarbon solvents, alkane solvents, halogenated alkane solvents, alcohol solvents, ketone solvents, ester solvents, ether solvents or nitrile solvents.
[0022] In some embodiments of the method for preparing compound (I) according to the present invention, the solvent used for pulping is selected from one or a mixed solvent of two or more of n-hexane, cyclohexane, methyl tert-butyl ether, petroleum ether and n-heptane.
[0023] In some embodiments of the method for preparing compound (I) according to the present invention, the solvent used for slurrying is selected from a mixed solution of n-hexane and methyl tert-butyl ether.
[0024] In some embodiments of the method for preparing compound (I) according to the present invention, the solvent used for pulping is selected from a mixed solution of n-hexane and methyl tert-butyl ether, with a volume ratio of 5 to 15:1, preferably 10:1.
[0025] In some embodiments of the method for preparing compound (I) according to the present invention, the aprotic solvent is selected from one or a mixed solvent of two or more selected from dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane and methyl tert-butyl ether, preferably tetrahydrofuran.
[0026] In some embodiments of the method for preparing compound (I) according to the present invention, the starting amount of the compound of formula (I-4) is greater than or equal to 500 g, preferably greater than or equal to 1 kg.
[0027] The present invention provides a method for preparing compound (III), which is prepared by the following reaction:
[0028] b. Add the compound of formula (I) and the organolithium reagent to an aprotic polar solvent at -70 to -30°C, maintain the reaction temperature at -70 to -30°C, add the aprotic polar solvent for the compound of formula (II), stir at -70 to -30°C for an appropriate time, and then raise the temperature to 0 to 25°C to react to obtain a compound of formula (III).
[0029] In some embodiments of the preparation method of compound (III) according to the present invention, step b is: adding a compound of formula (I) and an organic lithium reagent to an aprotic polar solvent at -45 to -35°C, maintaining the reaction liquid temperature at -45 to -35°C, adding an aprotic polar solvent for a compound of formula (II), stirring at -45 to -35°C for an appropriate time, and then heating to 0 to 25°C for reaction to obtain a compound of formula (III).
[0030] In some embodiments of the method for preparing compound (III) according to the present invention, the aprotic polar solvent in step b is selected from one or more of dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, methyl tert-butyl ether, cyclopentyl methyl ether, and dimethyl sulfoxide, preferably tetrahydrofuran; and the organic lithium reagent is selected from lithium diisopropylamide, n-butyl lithium or tert-butyl lithium, preferably lithium diisopropylamide.
[0031] In some embodiments of the method for preparing compound (III) according to the present invention, the aprotic polar solvent in step b is selected from tetrahydrofuran; and the organic lithium reagent is selected from lithium diisopropylamide.
[0032] In some embodiments of the method for preparing compound (III) of the present invention, before heating the reaction in step b, the temperature of the reaction solution is controlled at -70 to -30°C, preferably -45 to -35°C.
[0033] In some embodiments of the method for preparing compound (III) of the present invention, in step b, after the reaction of the compound of formula (I) and the compound of formula (II), further post-treatment is performed to obtain the compound of formula (III), and the post-treatment comprises: adding water, heating and stirring, cooling after a suitable time, concentrating, adding water, extracting with an organic solvent (1), collecting the aqueous phase, adding an organic solvent (2), cooling and stirring, adding an acidic reagent to adjust the acidity, separating the liquids, extracting with an organic solvent (2), combining the organic phases, drying, and concentrating.
[0034] In some embodiments of the method for preparing compound (III) of the present invention, the organic solvents (1) and (2) used for post-treatment in step b are selected from one or more mixed solvents of dichloromethane, 1,2-dichloroethane, ethyl acetate, diethyl ether, and 2-methyltetrahydrofuran.
[0035] In some embodiments of the method for preparing compound (III) according to the present invention, the organic solvent (1) used for post-treatment in step b is selected from ethyl acetate, and the organic solvent (2) is selected from 2-methyltetrahydrofuran.
[0036] In some embodiments of the method for preparing compound (III) according to the present invention, the acidic reagent used for the post-treatment in step b is selected from hydrochloric acid and sulfuric acid, preferably hydrochloric acid.
[0037] In some embodiments of the method for preparing compound (III) according to the present invention, the acidic range is adjusted to pH 2-4 in the post-treatment of step b.
[0038] In some embodiments of the method for preparing compound (III) according to the present invention, the acidic range is adjusted to pH 3.1 to 3.3 in the post-treatment of step b.
[0039] In some embodiments of the method for preparing compound (III) according to the present invention, the process for preparing compound (III) using compounds of formula (I) and formula (II) as raw materials does not include the step of beating and crystallizing (purification).
[0040] The present invention provides a method for preparing compound (V), which is prepared by the following reaction:
[0041] b. In an aprotic polar solvent, at -70 to -30 ° C, add the compound of formula (I) and the organolithium reagent, maintain the reaction temperature at -70 to -30 ° C, add the aprotic polar solvent of the compound of formula (II), stir at -70 to -30 ° C for an appropriate time, and then raise the temperature to 0 to 25 ° C to react to obtain a compound of formula (III);
[0042] c. Using the compound of formula (III) as a raw material to prepare the compound of formula (V), the compound of formula (III) and the compound of formula (IV) are added to an aprotic solvent at 0-25°C, and the reaction is carried out in the presence of an alkaline reagent. The crude product is post-treated to obtain the compound of formula (V).
[0043] In some embodiments of the method for preparing compound (V) according to the present invention, step b involves the preparation method of compound (III) which is the same as some embodiments of the method for preparing compound (III) described above.
[0044] In some embodiments of the method for preparing compound (V) according to the present invention, the post-treatment in step c comprises slurrying the crude product.
[0045] In some embodiments of the method for preparing compound (V) according to the present invention, the solvent used for slurrying in step c is selected from one or a mixed solvent of two or more of ethyl acetate, methyl acetate, isopropyl acetate, n-hexane, cyclohexane, methyl tert-butyl ether, petroleum ether and n-heptane.
[0046] In some embodiments of the method for preparing compound (V) according to the present invention, the solvent used for beating in step c is selected from ethyl acetate, and the beating temperature is 10-20°C.
[0047] In some embodiments of the method for preparing compound (V) according to the present invention, the post-treatment in step c comprises slurrying and crystallizing the crude product, the slurrying solvent is selected from ethyl acetate, and the crystallization solvent is selected from methyl tert-butyl ether.
[0048] In some embodiments of the method for preparing compound (V) according to the present invention, the aprotic solvent in step c is selected from dichloromethane, chloroform or 1,2-dichloroethane, preferably dichloromethane; and the alkaline reagent is selected from 1,8-diazabicyclo(5.4.0)undec-7-ene.
[0049] In some embodiments of the method for preparing compound (V) according to the present invention, the step of column chromatography is not included in the process of preparing compound (V) using compounds of formula (III) and formula (IV) as raw materials.
[0050] The present invention provides a method for preparing compound (VI), which is prepared by the following reaction:
[0051] b. In an aprotic polar solvent, at -70 to -30 ° C, add the compound of formula (I) and the organolithium reagent, maintain the reaction temperature at -70 to -30 ° C, add the aprotic polar solvent of the compound of formula (II), stir at -70 to -30 ° C for an appropriate time, and then raise the temperature to 0 to 25 ° C to react to obtain a compound of formula (III);
[0052] c. Using the compound of formula (III) as a raw material to prepare the compound of formula (V), the compound of formula (III) and the compound of formula (IV) are added to an aprotic solvent at 0 to 25° C., and the reaction is carried out in the presence of an alkaline reagent. The crude product is post-treated to obtain the compound of formula (V);
[0053] d. A silane reagent is added to the compound of formula (V) in an organic acid, and the compound of formula (VI) is obtained by post-treatment.
[0054] In some embodiments of the method for preparing compound (VI) according to the present invention, step b involves the preparation method of compound (III) which is the same as some embodiments of the method for preparing compound (III) described above.
[0055] In some embodiments of the method for preparing compound (VI) according to the present invention, step c involves the method for preparing compound (V) which is the same as some embodiments of the method for preparing compound (V) described above.
[0056] In some embodiments of the method for preparing compound (VI) according to the present invention, in step d, the organic acid is selected from trifluoroacetic acid, and the silane reagent is selected from triethylsilane.
[0057] The present invention provides a method for preparing compound (VII), which is prepared by the following reaction:
[0058] b. In an aprotic polar solvent, at -70 to -30 ° C, add the compound of formula (I) and the organolithium reagent, maintain the reaction temperature at -70 to -30 ° C, add the aprotic polar solvent of the compound of formula (II), stir at -70 to -30 ° C for an appropriate time, and then raise the temperature to 0 to 25 ° C to react to obtain a compound of formula (III);
[0059] c. Using the compound of formula (III) as a raw material to prepare the compound of formula (V), the compound of formula (III) and the compound of formula (IV) are added to an aprotic solvent at 0 to 25° C., and the reaction is carried out in the presence of an alkaline reagent. The crude product is post-treated to obtain the compound of formula (V);
[0060] d. Adding a silane reagent to the compound of formula (V) in an organic acid and post-treating to obtain a compound of formula (VI);
[0061] e. In an aprotic solvent, the compound of formula (VI) reacts with a salt-transfer reagent and is post-treated to obtain a compound of formula (VII).
[0062] In some embodiments of the method for preparing compound (VII) according to the present invention, step b involves the preparation method of compound (III) which is the same as some embodiments of the method for preparing compound (III) described above.
[0063] In some embodiments of the method for preparing compound (VII) according to the present invention, step c involves the method for preparing compound (V) which is the same as some embodiments of the method for preparing compound (V) described above.
[0064] In some embodiments of the method for preparing compound (VII) according to the present invention, step d involves the method for preparing compound (VI) which is the same as some embodiments of the method for preparing compound (VI) described above.
[0065] In some embodiments of the method for preparing compound (VII) according to the present invention, the salt transfer reagent in step e is selected from a solution of hydrogen chloride in ethyl acetate, a solution of hydrogen chloride in isopropyl acetate, a solution of hydrogen perchloride in methyl tert-butyl ether, or a solution of hydrogen chloride in dioxane, preferably a solution of hydrogen chloride in ethyl acetate; and the aprotic solvent is selected from one or more of dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, methyl tert-butyl ether, N,N-dimethylacetamide, N,N-dimethylformamide, and dimethyl sulfoxide, preferably acetonitrile.
[0066] In some embodiments of the method for preparing compound (VII) according to the present invention, the aprotic solvent in step e is selected from acetonitrile, and the salt transfer reagent is selected from a solution of hydrogen chloride in ethyl acetate, a solution of hydrogen chloride in isopropyl acetate, a solution of hydrogen chloride in methyl tert-butyl ether, or a solution of hydrogen chloride in dioxane.
[0067] In some embodiments of the method for preparing compound (VII) according to the present invention, the post-treatment in step e comprises purifying the crude product of formula (VII).
[0068] In some embodiments of the method for preparing compound (VII) according to the present invention, the post-treatment in step e comprises the following purification steps:
[0069] (1) Add isopropanol to the crude product of formula (VII), heat to 40-50°C, stir to dissolve, and filter while hot;
[0070] (2) Add methyl tert-butyl ether to the filtrate, control the temperature at 10-20°C, stir, filter, and wash the filter cake with methyl tert-butyl ether;
[0071] (3) repeating the refining steps (1) and (2) to obtain a refined wet product;
[0072] (4) Drying the wet product to obtain the compound of formula (VII).
[0073] The present invention provides a method for preparing compound (VII), which is prepared by the following reaction:
[0074] a. a compound of formula (I-4) undergoes a debenzylation reaction to produce a compound of formula (I);
[0075] b. reacting the compound of formula (I) with the compound of formula (II) to produce a compound of formula (III);
[0076] c. reacting the compound of formula (III) with the compound of formula (IV) to produce a compound of formula (V);
[0077] d. reacting the compound of formula (V) to produce the compound of formula (VI);
[0078] e. The compound of formula (VI) undergoes a salt conversion reaction to generate a compound of formula (VII).
[0079] In some embodiments of the method for preparing compound (VII) according to the present invention, the method comprises the following steps:
[0080] a. The compound of formula (I-4) reacts in the presence of an aprotic solvent, a catalyst Pd / C and hydrogen to produce a compound of formula (I); the amount of the catalyst Pd / C is 9 to 15% by mass of the compound of formula (I-4), and the aprotic solvent is selected from tetrahydrofuran;
[0081] b. adding the compound of formula (I) and the organolithium reagent in an aprotic polar solvent at -70 to -30°C, stirring for an appropriate time, and then heating to 0 to 25°C to react to obtain the compound of formula (III); or in some embodiments, b. adding the compound of formula (I) and the organolithium reagent in an aprotic polar solvent at -45 to -35°C, maintaining the reaction solution temperature at -45 to -35°C, adding the aprotic polar solvent for the compound of formula (II), stirring for an appropriate time, and then heating to 0 to 25°C to react to obtain the compound of formula (III); the aprotic polar solvent is selected from tetrahydrofuran, and the organolithium reagent is selected from lithium diisopropylamide;
[0082] c. reacting the compound of formula (III) and the compound of formula (IV) in dichloromethane at 0-25° C. in the presence of an alkaline reagent to obtain a compound of formula (V); the alkaline reagent is selected from 1,8-diazabicyclo(5.4.0)undec-7-ene;
[0083] d. The compound of formula (V) is dissolved in trifluoroacetic acid with stirring, triethylsilane is added to react, and the compound of formula (VI) is obtained by post-treatment;
[0084] e. The compound of formula (VI) reacts with a salt-transferring agent in acetonitrile, and the compound of formula (VII) is obtained after post-treatment; the salt-transferring agent is selected from a solution of hydrogen chloride in ethyl acetate.
[0085] Unless stated otherwise, the terms used in the specification and claims have the following meanings.
[0086] The elements carbon, hydrogen, oxygen, sulfur, nitrogen or halogen involved in the groups and compounds of the present invention include their isotopes, and the elements carbon, hydrogen, oxygen, sulfur or nitrogen involved in the groups and compounds of the present invention are optionally further replaced by 1 to 5 of their corresponding isotopes, wherein the isotopes of carbon include 12 C. 13 C and 14 C, hydrogen isotopes include protium (H), deuterium (D, also called heavy hydrogen), tritium (T, also called super tritium), oxygen isotopes include 16 O. 17 O and 18 O, sulfur isotopes include 32 S. 33 S. 34 S and 36 S, nitrogen isotopes include 14 N and 15 N, an isotope of fluorine 19 F, chlorine isotopes include 35 Cl and37 Isotopes of Cl, bromine include 79 Br and 81 Br.
[0087] The method of using extraction in the post-treatment of the reaction in the present invention is a conventional method in the art. The solvent for extraction can be selected according to the solubility of the product and the solubility of the organic solvent in water. Common extraction solvents include but are not limited to dichloromethane, chloroform, ethyl acetate, methyl acetate, isopropyl acetate, ether, isopropyl ether, methyl tert-butyl ether, methanol and ethanol, or a mixed solvent of two or more. The number of extractions can be appropriately increased or decreased according to the amount of product remaining in the aqueous phase. The organic phase after extraction is optionally further subjected to conventional washing and / or drying treatment in the art.
[0088] The separation method used in the present invention is a conventional separation method commonly used in the field of chemistry, such as silica gel column chromatography, high performance liquid chromatography, and thin layer chromatography.
[0089] "Silane reagent" refers to a hydrosilane compound containing a Si-H bond, including but not limited to simple alkylsilanes such as Et3SiH, Et2SiH2; different phenylsilanes such as Ph2SiH2, PhMe2SiH, Ph2MeSiH; alkylsiloxanes such as polymethylhydrogensiloxane (PMHS), diethoxymethylsilane (DEMS); halogenated silanes such as trichlorosilane.
[0090] "Salt transfer reagent" refers to an acid reagent formed by dissolving an acid in an organic solvent, wherein the organic solvent is selected from one or more of dichloromethane, chloroform, ethyl acetate, methyl acetate, isopropyl acetate, ethyl ether, isopropyl ether, dioxane, methyl tert-butyl ether, methanol and ethanol, and the acid is selected from hydrogen chloride, including but not limited to hydrogen chloride in ethyl acetate solution, hydrogen chloride in isopropyl acetate solution, hydrogen chloride in methyl tert-butyl ether solution or hydrogen chloride in dioxane solution.
[0091] "Alternatively" or "optionally" means that the subsequently described event or circumstance may but need not occur, including instances where the event or circumstance occurs or does not occur.
[0092] The reaction process of the present invention was analyzed by HPLC, 1 HNMR or thin layer chromatography was used to track the reaction progress and determine whether the reaction was complete.
[0093] "Closed reactor" refers to a reaction vessel in which the reaction system is in a closed state, such as a reactor or a sealed tube. DETAILED DESCRIPTION
[0094] The following describes in detail the implementation process of the present invention and the beneficial effects produced by specific embodiments, which is intended to help readers better understand the essence and characteristics of the present invention and is not intended to limit the scope of implementation of this case.
[0095] The structure of the compound is determined by nuclear magnetic resonance (NMR) or (and) mass spectrometry (MS), two-dimensional hydrogen isotope displacement correlation spectroscopy ( 1 H- 1 H COSY), two-dimensional nuclear Overhauser enhancement spectroscopy ( 1 H- 1 H NOESY) was used for stereoisomer analysis. NMR shift (δ) was measured at 10 -6 The units are given in ppm. NMR measurements were performed using a Bruker Avance III 400 NMR spectrometer. The solvents used were deuterated dimethyl sulfoxide (DMSO-d6), deuterated chloroform (CDCl3), deuterated methanol (CD3OD), and deuterated acetone. The internal standard was tetramethylsilane (TMS), and the external standard was 85% aqueous phosphoric acid.
[0096] MS was measured using Agilent 6120B (ESI) and Agilent 6120B (APCI).
[0097] HPLC analysis was performed using an Agilent 1260DAD high pressure liquid chromatograph (Zorbax SB-C18 100×4.6 mm).
[0098] The known starting materials of the present invention can be synthesized by methods known in the art, or can be purchased from companies such as Titan Technology, Anage Chemical, Shanghai Demer, Chengdu Kelon Chemical, Shaoyuan Chemical Technology, and Bailingwei Technology.
[0099] Unless otherwise specified in the examples, the solution refers to an aqueous solution.
[0100] Unless otherwise specified in the examples, the reaction temperature is room temperature.
[0101] The room temperature is 20℃~30℃.
[0102] OTs: p-toluenesulfonyl; Bn: benzyl; TBS: tert-butyldimethylsilyl; TMS: tetramethylsilyl; ACN: acetonitrile; DBU: 1,8-diazabicyclo(5.4.0)undec-7-ene; DCM: dichloromethane; EA: ethyl acetate; IPA: isopropanol; LDA: lithium diisopropylamide; MTBE: methyl tert-butyl ether; PMB: 4-methoxybenzyl; TFA: trifluoroacetic acid; THF: tetrahydrofuran.
[0103] Example 1
[0104] (2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid hydrochloride (VII)
[0105] (2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid hydrochloride(VII)
[0106] Step 1: L-dibenzyl aspartate (I-2)
[0107] dibenzyl L-aspartate(I-2)
[0108] Reaction: To a 50 L reactor, add 9.6 L of toluene and 14.4 L of cyclohexane. Start stirring, then add 3.001 kg of I-1, 14.624 kg of benzyl alcohol, and 5.359 kg of p-toluenesulfonic acid monohydrate in that order. Heat to 80-90°C and reflux for about 12 hours. The reaction is complete when monitored by LCMS.
[0109] Post-treatment: The reaction solution was cooled to 10±5°C, stirred for 2 hours, filtered, and the filter cake was slurried with 30 L of methyl tert-butyl ether for 0.5 h and filtered to obtain p-toluenesulfonate as a white solid, with a wet product of 14.321 kg.
[0110] Free: 80L of 1M potassium carbonate aqueous solution was added to a 100L reactor, stirred and cooled to 0-5°C, the above white solid salt was added, the temperature was controlled at 0-10°C, and stirred for about 1 hour. The aqueous phase was extracted three times with 20L of dichloromethane, the organic phases were combined, dried over anhydrous sodium sulfate, and the organic phase was concentrated under reduced pressure at 40°C until no obvious distillate flowed out to give 5.321kg of light yellow liquid, with a yield of 80.0%.
[0111] 1 H NMR (400MHz, CDCl3) δ7.44–7.12(m,10H),5.22–4.98(m,4H),3.88(dd,1H),2.98–2.62(m,2H),1.90(d,2H).
[0112] LCMS m / z=314.1[M+H] + .
[0113] Step 2: Benzyl (S)-4-oxazetidine-2-carboxylate (I-3)
[0114] benzyl(S)-4-oxoazetidine-2-carboxylate(I-3)
[0115] Reaction: Add 39L of tetrahydrofuran to a 100L reactor and start stirring. Under nitrogen protection, add 5000g of I-2 and 2011g of triethylamine in sequence, cool to -5°C, control the temperature at -5-0°C, add 2098g of trimethylsilyl chloride dropwise, and after the addition is complete, keep the temperature for 1 hour. Control the temperature at -5-0°C, then add 23.56L of tert-butylmagnesium chloride (1.7M tetrahydrofuran solution) dropwise. After the addition is complete, keep the temperature at 0-5°C for 2 hours. Sampling and testing, TLC (petroleum ether / ethyl acetate (v / v) = 1:1) monitors the disappearance of the raw material I-2, and the reaction is stopped.
[0116] Post-treatment: The temperature was controlled at 0-10°C, 30 L of 20% ammonium chloride solution was added to the reaction solution, and then the pH was adjusted to 6 with 1 M hydrochloric acid solution. The aqueous phase was extracted twice with 20 L of ethyl acetate, the organic phases were combined, washed with 20 L of 10% sodium chloride solution, and the organic phase was concentrated under reduced pressure at 45°C until no obvious fraction flowed out to obtain a crude product. 10 L of methyl tert-butyl ether was added and beaten for 2 hours. The crude product was filtered, and the filter cake was rinsed with 1 L of methyl tert-butyl ether and dried in vacuo at 50°C for about 16 hours to obtain 1598.0 g of a light yellow solid with a yield of 48.8%.
[0117] 1 H NMR (400MHz, DMSO) δ8.40(s,1H),7.42–7.27(m,5H),5.18(s,2H),4.20(dd,1H),3.25(dd,1H),2.91(d,1H).
[0118] LCMS m / z=206.1[M+H] + .
[0119] Step 3: (S)-1-(tert-butyldimethylsilyl)-4-oxoazetidine-2-carboxylic acid benzyl ester (I-4)
[0120] benzyl(S)-1-(tert-butyldimethylsilyl)-4-oxoazetidine-2-carboxylate(I-4)
[0121] Reaction: Add 16 L of dichloromethane to a 50 L reactor and start stirring. Then, add 1595.2 g of I-3 and 1505.1 g of N,N-diisopropylethylamine, followed by 1465.0 g of tert-butyldimethylsilyl chloride in batches. The reaction was allowed to react at room temperature for 18 hours. Samples were taken and monitored by TLC (petroleum ether / ethyl acetate (v / v) = 1:1) upon disappearance of the starting material, and the reaction was stopped.
[0122] Post-treatment: The organic phase was washed sequentially with 5 L of 20% aqueous ammonium chloride solution, 5 L of 3% aqueous citric acid solution, and 5 L of 20% brine, and dried over anhydrous sodium sulfate. The organic phase was concentrated under reduced pressure at 45°C until no obvious fraction flowed out, to obtain 2901 g of a brown liquid (yield: 100%), which was used directly in the next reaction.
[0123] 1 H NMR (400MHz, CDCl3) δ7.27(s,5H),5.09(s,2H),3.98(dd,1H),3.23(dd,1H),2.97(dd,1H),0.84(s,9H),0.15(s,3H),0.03(s,3H).
[0124] LCMS m / z=320.1[M+H] + .
[0125] Step 4: (S)-1-(tert-butyldimethylsilyl)-4-oxoazetidine-2-carboxylic acid (I)
[0126] (S)-1-(tert-butyldimethylsilyl)-4-oxoazetidine-2-carboxylic acid(I)
[0127] Reaction: To a 50-L reactor, add 16 L of tetrahydrofuran and, with stirring, sequentially add 2901.45 g of I-4 and 369.43 g of Pd / C (10% wt). The atmosphere was replaced with hydrogen three times. The reaction was hydrogenated at room temperature under a hydrogen atmosphere for approximately 24 hours. Samples were taken for monitoring by TLC (petroleum ether / ethyl acetate (v / v) = 1:1) upon disappearance of the starting material, and the reaction was stopped.
[0128] Post-treatment: Filter, concentrate under reduced pressure at 50°C until no obvious fraction flows out to obtain a crude product, add a mixed solution of 15L n-hexane and 1.5L methyl tert-butyl ether, stir and beat for 1 hour, filter, and rinse the filter cake twice with 2L n-hexane.
[0129] Drying: The filter cake was dried at 45±5°C under vacuum ≤-0.07 MPa for about 16 hours to obtain 1365.85 g of an off-white solid with a yield of 77.7%. HPLC: 99.852%.
[0130] 1 H NMR (400MHz, CDCl3) δ10.63(s,1H),3.92(dd,1H),3.24(dd,1H),2.97(dd,1H),0.80(s,9H),0.14(s,3H),0.00(s,3H).
[0131] LCMS m / z=230.1[M+H] + .
[0132] Step 5: (2S,3R)-3-((2-(bis(4-methoxybenzyl)amino)pyridin-4-yl)methyl)-4-oxoazetidine-2-carboxylic acid (III)
[0133] (2S,3R)-3-((2-(bis(4-methoxybenzyl)amino)pyridin-4-yl)methyl)-4-oxoazetidine-2-carboxylic acid(III)
[0134] Reaction: To a 100L reactor, 36.0kg of tetrahydrofuran and 2.0kg of I were added sequentially. The atmosphere was replaced with nitrogen three times. Under nitrogen protection, the temperature was lowered to -40±5°C and controlled at -40±5°C. 9.0L of lithium diisopropylamide (2M) was added dropwise. After addition, the mixture was stirred at -40±5°C for 1 hour. After temperature control at -40±5°C, a tetrahydrofuran solution of II (3.54kg of II dissolved in 16.0kg of tetrahydrofuran) was added dropwise. After addition, the mixture was stirred at -40±5°C for 2 hours. The mixture was heated to 15±5°C and reacted for approximately 12 hours. Sampling was monitored by HPLC. The reaction was stopped when the target value of II content was ≤20.0%.
[0135] Post-treatment: Add 20 kg of water to the reaction solution, heat to 60±5°C and stir for about 1 hour, cool to 30±5°C, concentrate tetrahydrofuran until no obvious fraction flows out. Add 10 kg of water, extract the aqueous phase with 15 kg of ethyl acetate three times, add 25 kg of 2-methyltetrahydrofuran to the aqueous phase, cool to 10±5°C, and add about 2.4 L of 6M hydrochloric acid dropwise with stirring to adjust the pH of the system to 3.1-3.3 (pH meter detection; if the pH is lower than 3.1 during adjustment, adjust it to 3.1-3.3 with 5% sodium bicarbonate solution), separate the liquid, and extract the aqueous phase again with 15 kg of 2-methyltetrahydrofuran twice. Combine the organic phases, dry with 5.0 kg of anhydrous magnesium sulfate for 1 hour, filter, wash the filter cake with 5 kg of 2-methyltetrahydrofuran, and combine the organic phases.
[0136] Concentration: Control the temperature at 40±5°C and concentrate under reduced pressure until no obvious fraction flows out. Continue concentrating under high vacuum for 1 hour to obtain intermediate III with a weight of 3.80 kg and a yield of 94.5%. HPLC: 93.607%.
[0137] 1 H NMR(400MHz, CDCl3)δ9.67(s,2H),7.99(d,1H),7.07(d,4H),6.78(d,4H),6.63– 6.54(m,2H),4.65(s,4H),3.70(d,6H),3.63(s,1H),3.28(s,1H),2.88(dd,2H).
[0138] LCMS m / z=462.2[M+H] + .
[0139] Step 6: (2S,3R)-3-((2-(bis(4-methoxybenzyl)amino)pyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid (V)
[0140] (2S,3R)-3-((2-(bis(4-methoxybenzyl)amino)pyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid(V)
[0141] Reaction: To a 100L reactor, add 20.22kg of dichloromethane and 3.80kg of III, sequentially. Replace the atmosphere with nitrogen twice. Under nitrogen protection, cool the temperature to 5±5°C and control the temperature at 10±5°C. Add 4.3951kg of DBU dropwise. After addition, control the temperature at 10±5°C. Add 2.5281kg of IV dropwise. After addition, raise the temperature to 20±5°C and react for approximately 16 hours. Samples were taken for HPLC monitoring. If the target value for III content was ≤2.0%, the reaction was stopped.
[0142] Post-treatment: After the reaction, 68.86 kg of methyl tert-butyl ether was added for slurrying and crystallization. After the addition was completed, the temperature was controlled at 15 ± 5 ° C and stirred for about 5 hours; filtered, the filter cake was washed with 4.68 kg of methyl tert-butyl ether, and the filter cake was transferred to the reactor again, 60.82 kg of ethyl acetate was added, the temperature was controlled at 15 ± 5 ° C and stirred for about 2 hours, filtered, and the filter cake was washed with 5.8 kg of ethyl acetate; the filter cake was repeatedly slurried once with 60.80 kg of ethyl acetate, and the filter cake was washed with 5.7 kg of ethyl acetate; the filter cake and 67.42 kg of dichloromethane were added to the reactor, stirred for about 0.5 hours, filtered, and insoluble matter was removed. The filter cake was washed with 3.80 kg of dichloromethane; the filtrate was transferred to the reactor, and the organic phase was washed twice with 19.02 kg of 10% citric acid solution (3.8163 kg of citric acid monohydrate was dissolved in 34.22 kg of water), and then with 19.12 kg The mixture was washed once with 10% sodium chloride solution (1.905 kg sodium chloride was dissolved in 17.22 kg water), separated, and the organic phase was dried with 2.549 kg magnesium sulfate for about 1 hour, filtered, and the filter cake was washed with 3.82 kg dichloromethane, and the organic phases were combined.
[0143] Concentration: The filtrate was concentrated under reduced pressure at 35±5°C until no obvious fraction flowed out. The filtrate was then concentrated under high vacuum for 1 hour to obtain intermediate V with a weight of 3.96 kg and a yield of 78.2%. HPLC: 97.447%.
[0144] 1 H NMR (400MHz, CDCl3) δ11.11(s,2H),8.02(d,1H),7.13(d,4H),6.82(d,5H),6.66(d,1H),6.33(d,1H),4.81(s,4H),4.19(d ,1H),3.75(s,6H),3.71–3.61(m,1H),3.49–3.41(m,1H),3.04(t,2H),1.66(dd,5H),1.37–1.26(m,1H),1.16–0.89(m,7H).
[0145] LCMS m / z=615.3[M+H] + .
[0146] Step 7: (2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid trifluoroacetate (VI)
[0147] (2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid trifluoroacetic acid(VI)
[0148] Reaction: To a 100L reactor, add 3.96kg of V and 30.56kg of trifluoroacetic acid, sequentially, under nitrogen atmosphere. Cool to 5±5°C and stir to dissolve. Maintain the temperature at 10±5°C, then add 3.00kg of triethylsilane dropwise. After addition, maintain the temperature at 25±5°C and allow to react for approximately 12 hours. Sample for HPLC monitoring. Stop the reaction when the target V content is ≤1.0%.
[0149] Post-treatment: After the reaction is completed, the reaction solution is concentrated under reduced pressure at 45±5°C until no obvious distillate flows out, 31.28 kg of acetonitrile is added, stirred for about 20 minutes, filtered, and the filtrate is extracted four times with 17.13 kg of n-hexane, separated, and the acetonitrile phases are combined.
[0150] Concentration: The acetonitrile phase was concentrated under reduced pressure at 45±5°C until no obvious fraction flowed out. The concentration was continued for 2 hours to obtain intermediate VI (yield calculated as 100%), which was directly used in the next reaction. HPLC: 83.376%.
[0151] LCMS m / z=375.2[M+H] + .
[0152] Step 8: (2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid hydrochloride (VII)
[0153] (2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((R)-1-cyclohexylethyl)carbamoyl)-4-oxoazetidine-2-carboxylic acid hydrochloride(VII)
[0154] Reaction: In a 100L reactor, dissolve the entire amount of VI in the previous step with 12.28kg of acetonitrile, stir for about 20 minutes, filter, transfer the filtrate to a reactor, cool to 10±5°C under nitrogen, and add dropwise 34.84kg of hydrogen chloride in ethyl acetate (11.46kg of hydrogen chloride in ethyl acetate dissolved in 23.38kg of ethyl acetate). After the addition is complete, heat to 20±5°C and stir for about 12 hours.
[0155] Post-treatment: After the reaction is completed, the reaction solution is cooled to 15±5°C and stirred for about 2 hours, filtered, and the filter cake is washed with 5.94 kg of ethyl acetate. The filter cake is collected and dried at 45±5°C and vacuum ≤-0.07 MPa for about 6 hours to obtain crude VII, with a weight of 1.69 kg. The yield is based on V, and the yield is 64.1%, HPLC: 99.028%.
[0156] Refining: To a 100L reactor, add 1.69kg of crude VII and 17.28kg of isopropanol, raise the temperature to 45±5°C, stir to dissolve, and filter while hot. Transfer the filtrate to a 100L reactor and add 32.52kg of methyl tert-butyl ether dropwise over approximately 1 hour. Stir at 15±5°C for approximately 2 hours, filter, and wash the filter cake with 3.39kg of methyl tert-butyl ether to obtain wet product 1. Repeat the purification process once to obtain wet product 2.
[0157] Drying: The wet product was dried at 45±5°C under vacuum ≤-0.07 MPa for about 25 hours to obtain VII with a yield of 60.0%, HPLC: 99.90%.
[0158] 1 H NMR (400MHz, DMSO) δ13.52(s,2H),8.08(s,2H),7.91(d,1H),7.07–6.74(m,2H),6.50(d,1H),4.20(d,1 H),3.69(td,1H),3.62–3.52(m,1H),3.15(d,2H),1.67(dd,5H),1.42–1.31(m,1H),1.22–0.83(m,8H).
[0159] LCMS m / z=375.2[M+H] + .
Claims
1. A method for preparing a compound of formula (I), in, In an aprotic solvent, a compound of formula (I-4) and a Pd / C catalyst are added, and a debenzylation reaction is carried out under a hydrogen atmosphere, and the compound of formula (I) is obtained after post-treatment; The amount of the catalyst Pd / C is 9 to 15% of the mass of the compound of formula (I-4).
2. The preparation method according to claim 1, wherein Post-processing includes pulping the crude product.
3. The preparation method according to claim 2, wherein The aprotic solvent is selected from one or more of dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane and methyl tert-butyl ether, preferably tetrahydrofuran; The solvent used for pulping is selected from one or a mixed solvent of two or more of n-hexane, cyclohexane, methyl tert-butyl ether, petroleum ether and n-heptane, preferably a mixed solution of n-hexane and methyl tert-butyl ether.
4. The preparation method according to claim 1, wherein The initial amount of the compound of formula (I-4) is greater than or equal to 500 g, preferably greater than or equal to 1 kg.
5. A method for preparing a compound of formula (III), wherein: b. Add the compound of formula (I) and the organolithium reagent to an aprotic polar solvent at -70 to -30°C, maintain the reaction temperature at -70 to -30°C, add the aprotic polar solvent for the compound of formula (II), stir at -70 to -30°C for an appropriate time, and then raise the temperature to 0 to 25°C to react to obtain a compound of formula (III).
6. A method for preparing a compound of formula (V), wherein: The steps include: Step b is consistent with that described in claim 5; c. Using the compound of formula (III) as a raw material to prepare the compound of formula (V), the compound of formula (III) and the compound of formula (IV) are added to an aprotic solvent at 0-25°C, and the reaction is carried out in the presence of an alkaline reagent. The crude product is post-treated to obtain the compound of formula (V).
7. A method for preparing a compound of formula (VI), wherein: The steps include: Step b is consistent with that described in claim 5; Step c is consistent with that described in claim 6; d. Using the compound of formula (V) as a raw material to prepare the compound of formula (VI), the compound of formula (V) is added with a silane reagent in an organic acid, and the compound of formula (VI) is obtained by post-treatment.
8. A method for preparing a compound of formula (VII), wherein: The steps include: Step b is consistent with that described in claim 5; Step c is consistent with that described in claim 6; Step d is consistent with that described in claim 7; e. Using the compound of formula (VI) as a raw material to prepare the compound of formula (VII), the compound of formula (VI) is reacted with a salt-transfer reagent in an aprotic solvent, and the compound of formula (VII) is obtained after post-treatment.
9. The preparation method according to any one of claims 5 to 8, wherein The aprotic polar solvent in step b is selected from one or more of dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, methyl tert-butyl ether, cyclopentyl methyl ether, and dimethyl sulfoxide, preferably tetrahydrofuran; In step b, the organolithium reagent is selected from lithium bistrimethylsilylamide, lithium diisopropylamide, n-butyllithium or tert-butyllithium, preferably lithium diisopropylamide.
10. The preparation method according to any one of claims 6 to 8, wherein: The post-treatment in step c includes slurrying the crude product.
11. The preparation method according to any one of claims 6 to 8, wherein: The solvent used for beating in step c is selected from ethyl acetate, and the beating temperature is 10-20°C.
12. The preparation method according to any one of claims 6 to 8, wherein: In step c, the aprotic solvent is selected from dichloromethane, chloroform or 1,2-dichloroethane, preferably dichloromethane; In step c, the alkaline reagent is selected from 1,8-diazabicyclo(5.4.0)undec-7-ene.
13. The preparation method according to any one of claims 7 to 8, wherein: In step d, the organic acid is selected from trifluoroacetic acid, and the silane reagent is selected from triethylsilane.
14. The preparation method according to claim 8, wherein: In step e, the salt transfer reagent is selected from a solution of hydrogen chloride in ethyl acetate, a solution of hydrogen chloride in isopropyl acetate, a solution of hydrogen chloride in methyl tert-butyl ether, or a solution of hydrogen chloride in dioxane, preferably a solution of hydrogen chloride in ethyl acetate; In step e, the aprotic solvent is selected from one or more of dichloromethane, chloroform, 1,2-dichloroethane, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, methyl tert-butyl ether, N,N-dimethylacetamide, N,N-dimethylformamide and dimethyl sulfoxide, preferably acetonitrile.
15. The preparation method according to claim 8, wherein The post-processing in step e includes the following refining steps: (1) Add isopropanol to the crude product of formula (VII), heat to 40-50°C, stir to dissolve, and filter while hot; (2) Add methyl tert-butyl ether to the filtrate, control the temperature at 10-20°C, stir, filter, and wash the filter cake with methyl tert-butyl ether; (3) repeating the refining steps (1) and (2) to obtain a refined wet product; (4) Drying the wet product to obtain the compound of formula (VII).
16. A method for preparing a compound of formula (VII), wherein: The method comprises the following steps: a. a compound of formula (I-4) undergoes a debenzylation reaction to produce a compound of formula (I); b. reacting the compound of formula (I) with the compound of formula (II) to produce a compound of formula (III); c. reacting the compound of formula (III) with the compound of formula (IV) to produce a compound of formula (V); d. reacting the compound of formula (V) to produce the compound of formula (VI); e. The compound of formula (VI) undergoes a salt conversion reaction to generate a compound of formula (VII).
17. The preparation method according to claim 16, characterized in that The method comprises the following steps: a. The compound of formula (I-4) reacts in the presence of an aprotic solvent, a catalyst Pd / C and hydrogen to produce a compound of formula (I); the amount of the catalyst Pd / C is 9 to 15% by mass of the compound of formula (I-4), and the aprotic solvent is selected from tetrahydrofuran; b. At -70 to -30°C, the compound of formula (I) and an organolithium reagent are mixed in an aprotic polar solvent, and an aprotic polar solvent for the compound of formula (II) is added. The mixture is stirred at -70 to -30°C for an appropriate time, and then the temperature is raised to 0 to 25°C to react to obtain a compound of formula (III); the aprotic polar solvent is selected from tetrahydrofuran, and the organolithium reagent is selected from lithium diisopropylamide; c. reacting the compound of formula (III) and the compound of formula (IV) in dichloromethane at 0-25° C. in the presence of an alkaline reagent to obtain a compound of formula (V); the alkaline reagent is selected from 1,8-diazabicyclo(5.4.0)undec-7-ene; d. The compound of formula (V) is dissolved in trifluoroacetic acid with stirring, triethylsilane is added to react, and the compound of formula (VI) is obtained by post-treatment; e. The compound of formula (VI) reacts with a salt-transferring agent in acetonitrile, and the compound of formula (VII) is obtained after post-treatment; the salt-transferring agent is selected from a solution of hydrogen chloride in ethyl acetate.
